Pulmonary artery catheterisation offers no benefitBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7571.720-a (Published 05 October 2006) Cite this as: BMJ 2006;333:720
- Toby Reynolds
Pulmonary artery catheterisation offers no demonstrable benefit for intensive care patients in the United Kingdom, a new research report says. Furthermore, economic analysis indicates that lives could be saved or prolonged at a modest cost by stopping its routine use, it concludes.
Such catheterisation has been a standard treatment in intensive care for almost 30 years, particularly in the United States. The authors, of the Intensive Care National Audit and Research Centre, London, note that the device was widely adopted without evidence of its benefit, on the assumption that detailed knowledge of haemodynamic variables would …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial